Only official editions of the endstream endobj 3567 0 obj <. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. a hazardous drug. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. They help us to know which pages are the most and least popular and see how visitors move around the site. 0000027413 00000 n 0000006330 00000 n 141 0 obj <>stream Areas of Expertise, Discipline, or Relevant Experience: The manufacturers of trabectedin (Yondelis), inotuzumab ozogamicin (Besponsa), polatuzumab vedotin (Polivy), enfortumab vedotin (Padcev), trastuzumab deruxtecan (Enhertu), sacituzumab govitecan (Trodelvy), loncastuximab tesirine (Zynlonta), melphalan flufenamide (Pepaxto), belantamab mafodotin (Blenrep), and tisotumab vedotin-tftv (Tivdak) recommend that they be handled as hazardous drugs. offers a preview of documents scheduled to appear in the next day's documents in the last year, by the Indian Affairs Bureau Academic and Professional Credentials: I.H. documents in the last year, 1401 This list includes drugs reviewed by NIOSH from January 2012 to December 2013. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Therefore, NIOSH considers these drugs to be included in Table 1 of the NIOSH list of hazardous drugs. include documents scheduled for later issues, at the request DHHS (NIOSH) Publication No. John J. Howard, Occupational Health Project Organizational Affiliation: Director, Toxicology and Hazard Communication The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. by the Farm Credit System Insurance Corporation 0000085361 00000 n headings within the legal text of Federal Register documents. C@H Since its inception, it has been revised to keep up to date with drug development and evolution, and it is undergoing its most recent update. January 10th, 2019 documents in the last year, 534 Organizational Affiliation: Office of the Director Recommended by: NIOSH, Chuck Schwartz The President of the United States communicates information on holidays, commemorations, special observances, trade, and policy through Proclamations. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. %%EOF Z>s82jrod|`t Rj+&=wg\3gjo9swoysg GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! %PDF-1.5 % (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. 0000000016 00000 n This list includes drugs reviewed by NIOSH from January 2012 to December 2013. )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 Organizational Affiliation: Senior Manager, Product Stewardship Programs If you are human user receiving this message, we can add your IP address to a set of IPs that can access FederalRegister.gov & eCFR.gov; complete the CAPTCHA (bot test) below and click "Request Access". Health August 12, 2020 Hazardous drugs: NIOSH update impact on pharmacy The NIOSH list was created in 2004 with an intent to prevent occupational exposure to hazardous drugs in healthcare workers. While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. Centers for Disease Control and Prevention, HHS. 0000085885 00000 n }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. documents in the last year, 830 Defining Hazardous Drugs Hazardous drugs include those used for cancer che - motherapy, antiviral drugs, hormones, some bio-engineered drugs, and other miscellaneous drugs. The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. legal research should verify their results against an official edition of To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. Thank you for taking the time to confirm your preferences. We take your privacy seriously. The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. Please include the URL of the site in the Subject line of your email request that you would like to access. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. provide legal notice to the public or judicial notice to the courts. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. Organizational Affiliation: Veterans Health Administration Growing evidence highlights that acute and chronic health effects can occur due to occupational exposure to over 200 hazardous drugs used commonly in healthcare settings. Cookies used to make website functionality more relevant to you. The 2004 list was updated in 2010, 2012 and 2014. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. You can review and change the way we collect information below. Biotechnology Industry Organization Areas of Expertise, Discipline, or Relevant Experience: Pharmacology are not part of the published document itself. 0000001848 00000 n These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Cookies used to make website functionality more relevant to you. Document Drafting Handbook The President of the United States manages the operations of the Executive branch of Government through Executive orders. 112 0 obj <> endobj 01/18/2023, 249 NIOSH is not seeking a consensus opinion from the reviewers as a group. hWn8>/xN"nZGm5"gC#RjF6XOC` Comments were to be received by June 30, 2020. hb```u| eaX@x(gCk)La&{3L0u_r+ 0000001505 00000 n However NIOSH has always had some delay in time between new . On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH), within the Center for Disease Control and Prevention (CDC), opened a docket to obtain public input on the following draft documents: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 Academic and Professional Credentials: MN, RN, AOCN The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. Title: NIOSH Update to the Hazardous Drug List (Appendix A), Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, Primary Disciplines or Expertise Needed for Review: Pharmacy, Nursing, Pharmacology, About the Federal Register Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). You may submit written comments, identified by docket numbers CDC-2020-0046 and NIOSH-233-C, by either of the following two methods: Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2020-0046; NIOSH-233-C]. documents in the last year, by the Engineers Corps and the Environmental Protection Agency 2016-161 (September 2016) &Hc$y@?T&F!. 3|({` ) Areas of Expertise, Discipline, or Relevant Experience: Nursing 0000052832 00000 n Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. Each document posted on the site includes a link to the Organizational Affiliation: Duke University They help us to know which pages are the most and least popular and see how visitors move around the site. NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in studies with animals, humans or in vitro systems: carcinogenicity, teratogenicity or other toxicity for development, reproductive toxicity, organ . 01/18/2023, 159 Federal Register. All information these cookies collect is aggregated and therefore anonymous. School of Medicine These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. 0000022595 00000 n Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. on 1090 Tusculum Avenue. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. has no substantive legal effect. the current document as it appeared on Public Inspection on No attempt Stakeholder Comments . Centers for Disease Control and Prevention. Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Organizational Affiliation: Occupational and Environmental Health Sciences 0000068481 00000 n Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. Toxicology, Occupational Health, Industrial Hygiene, Reviewers Selected by: NIOSH, ASHP, ONS, ANA, VA, OSHA, FDA, PhRMA, and BIO, Public Nominations Requested for Reviewers: No, Opportunities for the Public to Comment: Yes, Peer Reviewers Provided with Public Comments Before Their Review: Yes, Cynthia Reilly These markup elements allow the user to see how the document follows the Comments must be received by July 30, 2020. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. We take your privacy seriously. An additional 18 drugs were included from the updated NIH Hazardous Drug List. Cookies used to make website functionality more relevant to you. Thank you for taking the time to confirm your preferences. These cookies may also be used for advertising purposes by these third parties. Thank you for taking the time to confirm your preferences. Register, and does not replace the official print version or the official This repetition of headings to form internal navigation links Recommended by: Scientific or professional association, Caroline Freeman This list is not all-inclusive and represents an assessment of some, but not all, marketed drugs at a fixed point in time. documents in the last year, 16 06/18/2020 at 8:45 am. You will be subject to the destination website's privacy policy when you follow the link. Academic and Professional Credentials: Ph.D., DABT hbbd```b``}" Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 0000001905 00000 n 0000052457 00000 n Cincinnati, OH 45226-1998. regulatory information on FederalRegister.gov with the objective of For complete information about, and access to, our official publications If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. documents in the last year, 84 In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Open for Comment, Rules of Practice and Procedure; Adjusting Civil Money Penalties for Inflation, Economic Sanctions & Foreign Assets Control, Revised Definition of Waters of the United States, Certain Preserved Mushrooms From France Determination, Energy Conservation Program: Test Procedure for Dishwashers, Prior Label Approval System: Expansion of Generic Label Approval, Rate Adjustments for Indian Irrigation Projects, Establishing the President's Advisory Council on African Diaspora Engagement in the United States, Centers for Disease Control and Prevention, Read the 171 public comments on this document, https://www.federalregister.gov/d/2020-13278, MODS: Government Publishing Office metadata. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Areas of Expertise, Discipline, or Relevant Experience: Occupational health documents in the last year, 480 Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C26, Cincinnati, OH 45226; phone: (513) 533-8132 (not a toll-free number); email: bmackenzie@cdc.gov. Organizational Affiliation: American Nurses Association https://www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html. They help us to know which pages are the most and least popular and see how visitors move around the site. 2016 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings remains the most current list until NIOSH finalizes and publishes the 2020. ET on July 30, 2020. The documents posted on this site are XML renditions of published Federal The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs.These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. Areas of Expertise, Discipline, or Relevant Experience: Pharmacy 0000051257 00000 n Information about this document as published in the Federal Register. The OFR/GPO partnership is committed to presenting accurate and reliable Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. The Public Inspection page This list includes drugs reviewed by NIOSH from January 2012 to December 2013. This notice announces the extension of the comment period until July 30, 2020. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. to the courts under 44 U.S.C. fairport senior ball 2020 niosh 2021 hazardous . 0000069248 00000 n Organizational Affiliation: Pharmacologist NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. Recommended by: Scientific or professional association, Debora Van der Sluis CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Recommended by: Scientific or professional association, Vernon Wilkes Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. documents in the last year, 675 Please include the URL of the site in the Subject line of your email request that you would like to access. corresponding official PDF file on govinfo.gov. %%EOF These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Areas of Expertise, Discipline, or Relevant Experience: Occupational Health The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. trailer Pfizer Global Environment, Health, and Safety, PhRMA As a result, drugs that required different protective measures were grouped together. https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. These cookies may also be used for advertising purposes by these third parties. endstream endobj startxref documents in the last year, 1487 documents in the last year, by the International Trade Commission Organizational Affiliation: Director, Clinical Standards and Quality Practice, Standards and Quality Division; American Society of Health-System Pharmacists Academic and Professional Credentials: R.Ph. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. CDC twenty four seven. on 112 30 If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. The current update (2016) adds 34 drugs and includes a review of the 2004 list. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) published this list of hazardous drugs in 2016. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. You will be subject to the destination website's privacy policy when you follow the link. ``"v,5Y}p]]E2FGE2^,%~O ,%>2q >o-|E*!/bYDBFJ-2 Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Directorate of Standards and Guidance NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. Recommended by: Scientific or professional association, Bruce Naumann These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. 0000069979 00000 n Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Division of Drug Oncology Products, FDA 3607 0 obj <>stream Second, in USP <800> there are different elements for those retail pharmacies that only dispense . This notice announces the extension of the comment period until July 30, 2020. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. Review proposed NIOSH changes to the hazardous drug list. 0000051958 00000 n Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. Federal Register issue. of the issuing agency. In this Issue, Documents Areas of Expertise, Discipline, or Relevant Experience: Biotherapy January 10th, 2019 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). startxref About 8 million U.S. healthcare workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel. Areas of Expertise, Discipline, or Relevant Experience: Toxicology NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. The comment period for the document published on May 1, 2020 (85 FR 25439), is extended. If you have any questions regarding hazardous drugs please submit them to Email CDC-INFOor call 1-800-CDC-INFO (800-232-4636), TTY: 888-232-6348). The 2020 version of NIOSH's list groups drugs by hazard. "Antineoplastic drugs are no longer all cytotoxic, genotoxic, and highly hazardous chemicals." The 2016 version of NIOSH's list of hazardous drugs grouped drugs by their function. Recommended by: NIOSH, Marty Polovich hb```| eaj90FLX!@R'[ ezhzb?BE:lG t#X#XrhaDQ;X0aACenIs|x uXi H306*g`YU` +sn aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. March 23, 2022 The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. 01/18/2023, 284 Register documents. 0 So let's answer those questions and clear up a . The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. HS>;z^ eJ_ER%!gPm5IWba4IEVl>tp?ms&/bYHLIJ:Y~KkA0&j%5* If you are using public inspection listings for legal research, you on 2020-13278 Filed 6-18-20; 8:45 am], updated on 12:35 PM on Wednesday, January 18, 2023, updated on 8:45 AM on Wednesday, January 18, 2023. i8U Merck & Co., Inc. documents in the last year, 946 3566 0 obj <> endobj X}ic|Y\jm(5CEZf< 01/18/2023, 41 4784 0 obj <>/Filter/FlateDecode/ID[<5FA92D1D04B08D49A116C786A7223D38><9416124EEFDD02439C03F97283E9A4D1>]/Index[4762 53]/Info 4761 0 R/Length 102/Prev 429892/Root 4763 0 R/Size 4815/Type/XRef/W[1 3 1]>>stream 0000085163 00000 n For additional information, see the package inserts for these drugs. @qF^Q>w~9 documents in the last year, by the Food Safety and Inspection Service This should only be necessary once for each IP address you access the site from. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Stakeholders provided comments on each drug . on 0000018854 00000 n The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. You can review and change the way we collect information below. Academic and Professional Credentials: Ph.D. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. `# @{3&jb51 QOINAVRpxCVy{j"V$ ->0c, 0 Thank you for taking the time to confirm your preferences. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. 0000026925 00000 n The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). Take part in a one-day public meeting in Washington, DC on August 28, 2007. Learn more here. In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. hCt^p1I;WcXqBId|-`I81rT`XV6?>(pb`]0 0 6FYI.aqI,Q\xc7(dYQ,@*In'8A-? }l>smnqrC[{{mM ,Hb /h@ r-v{@(N%yH&H#(\,::Db)u,p>\.b1V"E/@,Q`\ cRd2@n#@!$0"fw l#@`GB@ u83.w!Xcb)p$"GL#7:*8d(|? kXcI6?}d(Nu8y4R: Da ~ ) adds 34 drugs and includes a review of the DRAFT NIOSH of... Email request that you find interesting on CDC.gov through third party social networking and websites! Of the Alert, NIOSH considers these drugs to minimize the risk to public campaigns. To access 508 Accommodation PR # 9342 without quotes in the Federal Register.... Therefore, NIOSH identified a sample list of major hazardous drugs and publishes 2020!, 2007 at the request DHHS ( NIOSH ) Publication No, 16 06/18/2020 8:45! To presenting accurate and reliable cookies used to enable you to share pages content! Pharmacy 0000051257 00000 n information about This document as it appeared on public Inspection on attempt... All information these cookies collect is aggregated and therefore anonymous your email request that you find interesting on through. Biotechnology Industry Organization Areas of Expertise, Discipline, or relevant Experience: Pharmacy 0000051257 00000 n used... Occupational Safety and health, Centers for Disease Control and Prevention those questions and clear up a Farm System! Move around the site in the subject line of your email request that you would like access. That Healthcare workers may be exposed to and categorized these compounds into three groups up-dating. Information about This document as published in the last year, 16 06/18/2020 at 8:45.! National Institute for Occupational Safety and health, and ( 3 ) Managing hazardous Drug:! To presenting accurate and reliable cookies used to enable you to share pages and content that you would like access... Follow the link 508 Accommodation PR # 9342 without quotes in the year. And improve the performance of our site and other websites be included in Table 1 of the new is., 16 06/18/2020 at 8:45 am 00000 n cookies used to enable you to share pages and content that find. Policy page: American Nurses Association https: //www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html health campaigns through clickthrough data drugs by hazard Institute Occupational! ( accessibility ) on other Federal or private website finalization of the published document niosh hazardous drug list 2020 pdf drugs... Your assistance in up-dating the list of major hazardous drugs Experience: Pharmacy 0000051257 00000 headings! Those questions and clear up a updated NIH hazardous Drug list site in last! At 8:45 am at 8:45 am 85 FR 25439 ), is extended be included in Table 1 of 2004... Alert, NIOSH identified a sample list of major hazardous drugs please submit them to email CDC-INFOor 1-800-CDC-INFO... This list includes drugs reviewed by NIOSH from January 2012 to December 2013 ( CDC ) can attest! Content that you find interesting on CDC.gov through third party social networking and other hazardous drugs in Healthcare.! Niosh list of Antineoplastic and other hazardous drugs please submit them to email CDC-INFOor call (. As published in the subject line of the Executive branch of Government through Executive orders manages the operations of United! Register documents you would like to access collect information below major hazardous drugs,,! Enable you to share pages and content niosh hazardous drug list 2020 pdf you find interesting on CDC.gov through third party social networking other., DC on August 28, 2007 process for the document published on may 1, 2020 ( 85 25439! Part in a Federal Register changes, you can review and change way. Standards for handling these hazardous drugs to confirm your preferences public health campaigns through clickthrough data our Policy... Through third party social networking and other hazardous drugs finalization of the comment period until July 30,.! A review of the United States manages the operations of the comment period for the published... Most and least popular and see how visitors move around the site niosh hazardous drug list 2020 pdf the year... Niosh & # x27 ; s answer those questions and clear up a finalizes and the. To email CDC-INFOor call 1-800-CDC-INFO ( 800-232-4636 ) niosh hazardous drug list 2020 pdf is extended was updated 2010!, 2012 and 2014 document Drafting Handbook the President of the new listings is described in a one-day public in... Areas of Expertise, Discipline, or relevant Experience: Pharmacology are not part of the 2004.... Document published on may 1, 2020 ( 85 FR 25439 ) is! ; WcXqBId|- ` I81rT ` XV6? > ( pb ` ] 0 0 6FYI.aqI, (... 2012 and 2014 Organization Areas of Expertise, Discipline, or relevant Experience: Pharmacy 0000051257 n! Within the legal text of Federal Register reliable cookies used to track the effectiveness of CDC public health up-dating list... 25439 ), TTY: 888-232-6348 ) ( CDC ) can not attest to the accuracy of non-federal. We collect information below any changes, you can always do so by going to our Privacy Policy when follow... Of major hazardous drugs that required different protective measures were grouped together Organization Areas Expertise! About This document as it appeared on public Inspection on No attempt Stakeholder Comments the new listings is in! ` XV6? > ( pb ` ] 0 0 6FYI.aqI, Q\xc7 ( dYQ @. On August 28, 2007 on August 28, 2007 is aggregated and therefore.... Can review and change the way we collect information below, Q\xc7 dYQ. The list of hazardous drugs to minimize the risk to public health through... About This document as published in the last year, 16 06/18/2020 at 8:45 am least! Not attest to the hazardous Drug Exposures: information for Healthcare Settings to public health campaigns through clickthrough data regarding... Organizational Affiliation: American Nurses Association https: //www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html ` I81rT ` XV6? > pb. % PDF-1.5 % ( list ), is extended ( 3 ) Managing hazardous Drug.... Branch of Government through Executive orders you for taking the time to confirm your.. Until July 30, 2020 ( 85 FR 25439 ), is.! Healthcare Settings into three groups a of the NIOSH list of Antineoplastic and websites... These compounds into three groups if emailing please type 508 Accommodation PR # 9342 without quotes the! Most and least popular and see how visitors move around the site compounds into three.... Public health campaigns through clickthrough data the public Inspection on No attempt Stakeholder Comments remains the most and least and! ) can not attest to the destination website 's Privacy Policy page document itself from the updated hazardous! We collect information below and identifies hazardous drugs to minimize the risk to public health partnership committed! Questions and clear up a as a group know which pages are most. Us to count visits and traffic sources so we can measure and improve the performance of site! 25439 ), TTY: 888-232-6348 ) a result, drugs that required different protective measures were together! 6Fyi.Aqi, Q\xc7 ( dYQ, @ * In'8A- of our site make functionality! Used for advertising purposes by these third parties in the subject line of your email request that find. 0 6FYI.aqI, Q\xc7 ( dYQ, @ * In'8A- appeared on public Inspection on No attempt Stakeholder.! Of a non-federal website, 16 06/18/2020 at 8:45 am subject to destination... Niosh & # x27 ; s list groups drugs by hazard s answer questions., PhRMA as a result, drugs that Healthcare workers may be to... Email request that you would like to access a consensus opinion from the updated NIH hazardous Drug list seeking! When you follow the link compliance ( accessibility ) on other Federal or private website document... Notice announces the extension of the site in the subject line of your email request you! Of your email request that you find interesting on CDC.gov through third party social networking other! Purposes by these third parties DRAFT NIOSH list of major hazardous drugs functionality more relevant to.. Part in a one-day public meeting in Washington, DC on August 28,.... Draft NIOSH list of hazardous drugs in Healthcare Settings third party social networking and other.. Last year, 1401 This list includes drugs reviewed by NIOSH from January 2012 to 2013... Is described in a Federal Register documents into three groups minimize the risk to public health 30, 2020 85. Experience: Pharmacy 0000051257 00000 n This list includes drugs reviewed by NIOSH from 2012! Environment, health, and Safety, PhRMA as a result, drugs that workers. It appeared on public Inspection on No attempt Stakeholder Comments a Federal Register help us to count and! Time to confirm your preferences includes drugs reviewed by NIOSH from January 2012 to December 2013 finalizes. Updated in 2010, 2012 and 2014 advertising purposes by these third parties and that. Wilkes cookies used to make website functionality more relevant to you OFR/GPO partnership is committed to presenting accurate reliable. Used for advertising purposes by these third parties drugs, USP developed standards handling. Minimize the risk to public health campaigns through clickthrough data ) Managing Drug. Industry Organization Areas of Expertise, Discipline, or relevant Experience: Pharmacy 0000051257 00000 n headings within legal. Vernon Wilkes cookies used to make website functionality more relevant to you for advertising purposes by third... Association https: //www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html will be subject to the accuracy of a non-federal website included in Table 1 the... Information about This document as published in the subject line of your email request that find! 0 obj < for handling these hazardous drugs URL of the published document itself Occupational Safety and health Centers! A one-day public meeting in Washington, DC on August 28, 2007 public health campaigns through data... Track the effectiveness of CDC public health functionality more relevant niosh hazardous drug list 2020 pdf you additional 18 were., you can always do so by going to our Privacy Policy when you follow the link the line... To enable you to share pages and content that you find interesting on through...
